PLA2R1 and kidney disorder: Here, we employed a highly sensitive time-resolved fluoroimmunoassay (TRFIA), to quantitatively detect anti-PLA2R antibodies in serum (Fig. 1), and then used the method to detect anti-PLA2R antibodies in the serum of kidney disease patients.